Late-Onset Ocular Myasthenia Gravis-Like Symptoms During Erenumab Therapy for Chronic Migraine: A Case Report. [PDF]
Qaqish A, Al Anber A, Abdelhafez G.
europepmc +1 more source
Vascular models to study migraine:From human isolated blood vessels to vessel-on-chip [PDF]
In this thesis, the vascular effects of CGRP and novel pharmacological treatment of migraine targeting CGRP (receptors) are investigated. CGRP is a neuropeptide that is involved in migraine pathophysiology, but is also a potent vasodilator that can offer
de Vries, Tessa
core
Effect of Erenumab on Patient-Reported Outcomes in Episodic Migraine in Asia, the Middle East, and Latin America: Results From the EMPOwER Study. [PDF]
Wang SJ +14 more
europepmc +1 more source
Prescriber adherence to treatment guidelines for monoclonal antibodies against Calcitonin Gene-Related Peptide in migraine prophylaxis - a register-based cohort study. [PDF]
Nordenmalm S +5 more
europepmc +1 more source
NON-MIGRAINE RELATED PAIN BEHAVIOURS IN A TRANSGENIC "MIGRAINE MOUSE" WITH CIRCADIAN DISRUPTION [PDF]
Goadsby, Peter J +6 more
core +1 more source
Multiple Sclerosis With Migraine and Pyoderma Gangrenosum Treated With Ofatumumab and Erenumab. [PDF]
Motegi H +4 more
europepmc +1 more source
Comprehensive assessment of erenumab efficacy in participants with high-frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study. [PDF]
Paiva da Silva Lima G +11 more
europepmc +1 more source
Impact of Erenumab on Comorbid Depression, Anxiety, and Sleep Quality in Migraine: A Registry for Migraine (REFORM) Study. [PDF]
Raffaelli B +7 more
europepmc +1 more source
CGRP and Migraine: Real-World Insights and Future Therapeutic Directions. [PDF]
Russo AF, Kaiser EA.
europepmc +1 more source
Normal delivery following use of galcanezumab until the first and second trimesters of pregnancy: A report of 2 cases. [PDF]
Akiyama H, Yamano Y.
europepmc +1 more source

